Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/A4FDCC4D.svg?ark=w1%2F20260515%2FA4FDCC4D&value=id)](https://nobleid.org/work/w1/20260515/A4FDCC4D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors